News

TORONTO and PHILADELPHIA — February 27, 2026 —Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) today announced a partnership focused on making patient-centered Friedreich’s ataxia (FA) data more accessible and actionable to help accelerate the development of treatments for FA. As part of the collaboration, Everest Clinical Research will serve as a biostatistics…

Expansion will strengthen global biometrics delivery and support continued growth across the globe TORONTO — February 3, 2026 –Everest Clinical Research, a leading full-service contract research organization (CRO) with deep biometrics foundations, announces the expansion of its Asia Pacific operations with the establishment of a new biometrics team in the Philippines. The company expects to…

TORONTO – November 24, 2025 – Everest Clinical Research— a data-driven and quality-focused global CRO — is pleased to announce the establishment of a dedicated biometrics team, providing clinical data management, biostatistics, and statistical programming services in Warsaw, Poland. This strategic expansion builds on Everest’s already strong presence in Poland, where the company provides local…

TORONTO — July 30, 2025 — Everest Clinical Research, a quality and data-driven global CRO, announces the appointment of Kevin Barber, Ph.D., M.S., RAC, PMP as Senior Vice President of Global Regulatory Strategy and Submissions. In this role, Kevin will lead the expansion of Everest’s regulatory capabilities, overseeing strategy and execution from early clinical development planning…

TORONTO –June 5, 2025 – Medidata, a Dassault Systèmes brand, today announced that Everest Clinical Research, a global full-service

TORONTO  – February 13, 2025 – Everest Clinical Research Corporation (Everest), a global full-service Contract Research Organization (CRO), announces the promotion of Jin Dai from her current position of Chief Operating Officer (COO) to the position of Chief Executive Officer (CEO). At the same time, the company appoints Rob Woolson as its new Chief Operating Officer…

TORONTO —November 7, 2023—Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in clinical data management, biostatistics and statistical programming, today announced it has acquired August Research (“August”). Everest is a portfolio company of Arlington Capital Partners (“Arlington”), a Washington, D.C. based private equity firm with extensive experience investing in…

TORONTO – December 1, 2022 – Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise in biostatistics and statistical programming, today announced it has acquired Brightech International (“Brightech”). Founded in 2002, Brightech is a leading CRO that specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to…

By integrating data across disparate systems, insights into trial operations, data integrity and patient information are centralized at your finger tips. Everest has leveraged its strong foundation in data and analytics to provide clinical data dashboard solutions to our clients. The Dashboard initiative brings together data across clinical trial systems – which includes EDC, IWRS/IRT,…

Over the past 16 years we have built a solid foundation for future growth. Our reputation for quality, and strong track record of success support our plan for accelerated growth in 2021 and years beyond. Everest’s growth is accelerating. We have grown steadily and organically for the past 16 years and have focused on delivering…